AstraZeneca
AZN
AZN
1,049 hedge funds and large institutions have $35B invested in AstraZeneca in 2023 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 406 increasing their positions, 348 reducing their positions, and 69 closing their positions.
Holders
1,049
Holders Change
-8
Holders Change %
-0.76%
% of All Funds
16.79%
Holding in Top 10
13
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-31.58%
% of All Funds
0.21%
New
85
Increased
406
Reduced
348
Closed
69
Calls
$487M
Puts
$466M
Net Calls
+$21.3M
Net Calls Change
+$20.1M
Top Buyers
| 1 |
1
Jennison Associates
New York
|
$1.12B |
| 2 |
2
GQG Partners
Ft. Lauderdale,
Florida
|
$1.5B |
| 3 |
3
Morgan Stanley
New York
|
$899M |
| 4 |
4
Goldman Sachs
New York
|
$645M |
| 5 |
5
Envestnet Asset Management
Chicago,
Illinois
|
$120M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WVP
1126
Worth Venture Partners
Fort Lee,
New Jersey
| – | – | – | – |
|
1127
Capital Fund Management (CFM)
Paris,
France
| – | – | – | – |
|
1128
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|